Matthew Babich, DPM
Foot & Ankle Surgery · Dallas, TXNPI 1659436632
Payments from drug & device makers
Across 170 payments — averaging $95.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$10K
- Organogenesis Inc.$2K
- Stryker$2K
- Integra Lifesciences Corporation$479
- Omeza LLC$416
- Vaporox, Inc.$347
- plus $1K from 24 others
What the payments were for
- Speaking & faculty fees$8,40052%
- Food & beverage$7,56047%
- Gifts$2472%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 8 | $9,716 |
| Organogenesis Inc. | 64 | $2,186 |
| Stryker(2 entities) | 23 | $1,642 |
| Integra Lifesciences Corporation | 7 | $479 |
| Omeza LLC | 5 | $416 |
| Vaporox, Inc. | 4 | $347 |
| Smith+Nephew | 13 | $264 |
| Lifenet Health | 1 | $211 |
| Orthofix Medical, Inc. | 9 | $161 |
| Merck | 1 | $96 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $95 |
| KCI USA, Inc. | 4 | $95 |
| Aroa Biosurgery Incorporated | 6 | $59 |
| Axogen | 2 | $54 |
| Misonix Inc | 1 | $53 |
| Bioventus LLC | 2 | $43 |
| Melinta Therapeutics, LLC | 3 | $38 |
| Tactile Systems Technology Inc | 2 | $32 |
| Hartmann USA, Inc. | 1 | $28 |
| Inari Medical, Inc. | 1 | $26 |
| Osiris Therapeutics Inc. | 2 | $26 |
| Linvatec Corporation | 1 | $22 |
| Medtronic | 1 | $19 |
| Averitas Pharma Inc. | 1 | $18 |
| Convatec Inc. | 1 | $15 |
| Hydrofera LLC | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Nuo Therapeutics | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $13 |
| Trice Medical, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Wound$9,157
- Kerecis Omega3 SurgiClose$5,855
- Kerecis Omega3 GraftGuide$5,254
- Kerecis Omega3 Surgibind$4,900
- Kerecis Omega3 Marigen$1,064
- AUGMENT INJECTABLE$617
- PuraPly$558
- CYTAL$517
- TheraGenesis Wound Matrix$211
- CITREFIX$157
- SALVATION$150
- VHT-200 Wound Treatment System$147
- Viaflow$141
- ACTISHIELD CF$141
- Affinity$125
- OMNIGRAFT$121
- TCC-EZ$121
- PRIMATRIX$121
- Puraply Antimicrobial$120
- ORTHOLOC$109
How this compares
$16,207 in reported general payments places this provider in the 75th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 26 | $163 |
| Ciprofloxacin Hcl | 16 | $92 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Dallas
- Eugene CurryDallas$3.1M
- Paul KimDallas$972K
- John EarlyDallas$572K
- John NoackDallas$389K
- Dane WukichDallas$273K
- Charles CookDallas$192K
- George LiuDallas$130K
- Trapper LalliDallas$92K
- Veerabhadra ReddyDallas$59K
- Richard PollakSan Antonio$6.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.